RE50-0323 — Uther Retatrutide
Vendor COAUther | Retatrutide, last activity 2 months ago
One positive report has been raised. The vendor's Janoshik certificate reports 99.82% purity and 54.93 mg measured fill, in line with Uther's other retatrutide batches. No independent test has been submitted. First seen within the last month.
13 related batch concerns · 2 mentions · summary from 3 sources · updated Aug 15
Get notified when a lab result is posted, a group test forms, or this batch is flagged by the community.
Test Results
The label says 50 mg. Janoshik weighed 54.9 mg — 10% more than the label. Your dose depends on what is really in the vial, so the steps below use the measured amount.
Draw
18 units
on a U-100 insulin syringe, for 5 mg
Going by the label you would draw 20 units — which from this vial is actually 5.49 mg, not 5 mg.
- The vial holds dry powder: 54.9 mg of Retatrutide, as weighed.
- Water spreads that powder evenly through the liquid: 54.9 mg ÷ 2 ml = 27.5 mg per ml.
- An insulin syringe counts in units, 100 to the ml, so each unit carries 275 mcg.
- Your dose divided by that: 5 mg ÷ 275 mcg = 18 units.
The water changes how many units a dose takes, never how much peptide you get. Twice the water means twice the units for the same dose. What sets the dose is how much is in the vial — which is why the measured amount matters.
Arithmetic, not medical advice. Assumes a U-100 syringe and that the powder fully dissolves. The figure is from the vial that was tested; yours is from the same lot but was not weighed itself.
Related batches
5 of 5 tested
same lot series
One quality concern was raised alongside positive feedback
also Uther
Uther's Janoshik certificate reports 99.18% purity and passed sterility, in line with this vendor's other retatrutide…
PT-141, same vendor
One concern was raised about this batch
APS
An independent test found endotoxin at 1,437.86 EU/vial, far exceeding the 10 EU/vial working limit, while the vendor's…
also Uther
Uther's Janoshik certificate reports 99.81% purity and a measured fill of 43.087 mg, with sterility passing
Community Intelligence
- 1 concern report involving RE10-0625
- 1 concern report involving RE400719
- 1 concern report involving RE20-0720
- 1 concern report involving RE20-0904
- 1 concern report involving RE50-0722
- 1 concern report involving RE20-0724
- 1 concern report involving PT10-0528
- 2 concern reports involving PT10-0617
- 1 concern report involving REPTN
- 2 concern reports involving 2026041210
- 4 concern reports involving XTP-R30-003
- 1 concern report involving JP20250821
- 1 concern report involving REPTN-1
Reported against other Uther Retatrutide batches, not this one.
Also known as: RE500323
Activity
This is the summer special. https://janoshik.com/tests/136874-reta50mg_RE500323_PRZUICZAN1UE
View in Telegram →members onlyuther pharmaceutical: https://janoshik.com/tests/136874-reta50mg_RE500323_PRZUICZAN1UE https://verify.janoshik.com/tests/156970-fox04_10mg_FOX100502_WS5IJUQQS9IE https://janoshik.com/tests/164334-Na...
View in Telegram →members onlyVendor
Uther